Skip to main content
. Author manuscript; available in PMC: 2015 Mar 24.
Published in final edited form as: JPEN J Parenter Enteral Nutr. 2013 Jun 11;38(5):608–616. doi: 10.1177/0148607113491436

Figure 6.

Figure 6

Hepatic peroxisome proliferator-activated receptor–α (PPAR-α) messenger RNA (mRNA) in controls, PN-O, PN–ω-6, and PN–ω-3 groups. Values are shown as means ± SD (P = not significant among all groups). PN-O, oral, fat-free parenteral nutrition (PN) solution only; PN–ω-6, PN-O plus intraperitoneal (IP) ω-6 fatty acid (FA)–predominant supplements; PN–ω-3, PN-O plus IP ω-3 FA.